Advanced Therapeutics
Biomedical Engineering, Science & Health Systems
Cell and gene therapies are rapidly expanding and are expected to entirely transform many areas of medicine. The MS in Advanced Therapeutics program from the School of Biomedical Engineering, Science and Health Systems allows students to learn about the design and development of next generation therapeutics known as cell and gene therapy (CGT), immunotherapy and immune engineering, genomics and personalized medicine. This is a hands-on, interdisciplinary program that utilizes the expertise of multiple academic units and leverages various industry partnerships in the Philadelphia’s Cellicon Valley, home to the first FDA-approved cell and gene therapies. Philadelphia and its surrounding region are home to over 15% of the world's cell and gene therapy companies.
This program aligns with the School’s mission of educating and empowering the next generations of diverse biomedical innovators through novel interdisciplinary research and immersive learning to equitably transform the future of health and humanity.
Degree | Availability | Location |
---|---|---|
MS |
Full-Time |
Philadelphia |